What Happened?
Shares of health care services provider Encompass Health (NYSE: EHC) jumped 13.2% in the afternoon session after the company reported second-quarter earnings that surpassed analyst expectations for both revenue and profit.
The healthcare provider announced revenue of $1.6 billion for the quarter, an increase of 9.6% from the same period last year and 1.8% above estimates. Adjusted earnings per share (EPS) came in at $1.55, which was 4.7% higher than the consensus forecast of $1.48.
The strong performance in both key financial metrics, alongside a raised full-year profit outlook, indicated healthy growth for the company, driving positive investor sentiment.
Is now the time to buy Encompass Health? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Encompass Health’s shares are not very volatile and have only had 6 moves greater than 5% over the last year. Moves this big are rare for Encompass Health and indicate this news significantly impacted the market’s perception of the business.
The biggest move we wrote about over the last year was 6 months ago when the stock gained 11.9% on the news that the company reported strong fourth-quarter earnings and raised its profit forecast for the full year 2026. The healthcare provider announced fourth-quarter adjusted earnings of $1.46 per share, significantly beating the consensus estimate of $1.30. Revenue for the quarter rose 9.9% year on year to $1.54 billion, which met Wall Street's expectations. However, the key driver for the stock's move appeared to be the company's optimistic outlook. Encompass Health guided for full-year 2026 adjusted earnings per share of $5.96 at the midpoint, which surpassed analyst projections. This positive guidance, coupled with improved operating and free cash flow margins in the quarter, suggested strong underlying business health and boosted investor confidence.
Encompass Health is up 17.8% since the beginning of the year, and at $125.36 per share, it is trading close to its 52-week high of $127.18 from October 2025. Investors who bought $1,000 worth of Encompass Health’s shares 5 years ago would now be looking at an investment worth $1,552.
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.
